EuGMS Task Force on COVID-19
Reach us covid19taskforce(at)eugms.org
Please consult the EuGMS Statement on COVID-19
WHO-Europe dashboard on COVID-19
WHO-Global dashboard on COVID-19
SPRINGER NATURE-Articles on COVID-19 (all articles are free access)
As a leading research publisher and EuGMS EGM Journal partner, Springer Nature is committed to supporting the global response to emerging outbreaks by enabling fast and direct access to the latest available research, evidence, and data.
TOPIC 50
Country of origin: Norway
Nursing home deaths after COVID-19 vaccination
TOPIC 49
Country of origin: --
TOPIC 48
Country of origin: --
TOPIC 47
Country of origin: --
The EU-COGER study from the EuGMS SIG on Geriatric Rehabilitation
https://www.eugms.org/news/read/article/535.html
TOPIC 46
Country of origin: UK
OXFORD UNIVERSITY PRESS’S COVID-19 RELATED CONTENT
https://academic.oup.com/journals/pages/coronavirus
https://blog.oup.com/category/science_medicine/covid-19/
TOPIC 45
Country of origin: UK
BGS COVID-19 RELATED CONTENT
https://academic.oup.com/ageing/pages/covid-19
https://www.bgs.org.uk/resources/age-and-ageing-journal-free-collection-of-covid-19-papers
TOPIC 44
Country of origin: - -
Council of Europe - Statement: Lessons to be drawn from the ravages of the COVID-19 pandemic in long-term care facilities
TOPIC 43
Country of origin: UK
BGS - Age and Ageing: COVID-19 in Older People: A Rapid Clinical Review
TOPIC 42
Country of origin: Italy
Now available online the recording of the webinar:
SIGOT - Webinar "L'anziano e la pandemia da COVID-19: epidemiologia e clinica nei diversi setting di cura"
Chairs: Prof Alberto Ferrari, Prof Filippo Fimognari, Prof Alberto Pilotto (see Topic 36)
TOPIC 41
Country of origin: Poland
Information and Recommendations from the Polish College of Geriatricians [POLISH]
Information and Recommendations from the Polish Society of Gerontology [POLISH]
TOPIC 40
Country of origin: UK
British Geriatrics Society - Age and Ageing journal: Free collection of COVID-19 papers
TOPIC 39
Country of origin: --
EuGMS Special Interest Group on Geriatric Rehabilitation - Response to COVID-19
For more information visit the SIG on Geriatric Rehabilitation page.
TOPIC 38
Country of origin: Turkey
1) Prevention Advices for Covid-19 Disease for Nursing Homes by the Turkish Academic Geriatrics Society
2) Protection and Control Recommendations for nursing homes and elderly care centers by the Turkish Ministry of Family Labor and Social Services of the Turkish Republic
3) Public information brochure for Covid-19 by Turkish Academic Geriatrics Society
4) Kamu bilgilendirme bro?ürü Uzman gözüyle ya?l?da COVID Akademik Geriatri Derne?i [TURKISH]
5) Links for simple exercises video that can be performed at home for older adults by the Turkish Academic Geriatrics Society [Türkçe] [TURKISH]
http://www.akademikgeriatri.org/index.php?func=new_content&id=89
https://www.youtube.com/watch?v=2Ka-MMBF7E4
6) Public Information for Coronavirus and older adults by the Elderly Platform
TOPIC 37
Country of origin: Italy
SIGOT - Forum OLDER ADULTS AND COVID-19 [ITALIAN]
TOPIC 36
Country of origin: Italy
SIGOT - Webinar "L'anziano e la pandemia da COVID-19: epidemiologia e clinica nei diversi setting di cura"
Charis: Prof Alberto Ferrari, Prof Filippo Fimognari, Prof Alberto Pilotto
Programme for download [ITALIAN]
TOPIC 35
Country of origin: -
EuGMS Letter to ECDC European Centre for Disease Prevention and Control
TOPIC 34
Country of origin: CHINA
TOPIC 33
Country of origin: -
EuGMS Recommendations for safety and protection of Care Homes against COVID-19 -UPDATE1
TOPIC 32
Country of origin: UK
BGS - Atypical Covid-19 presentations in older people – the need for continued vigilance
TOPIC 31
Country of origin: UK
TOPIC 30
Country of origin: -
EICA - CoVID-19 Concepts and Their Application to Geriatrics
TOPIC 29
Country of origin: SPAIN
COLLABORATION BETWEEN HOSPITAL GERIATRIC SERVICES - HOSPITAL HALF-STAY - NURSING HOMES AND SOCIAL HEALTH CENTRES [SPANISH TEXT]
SEGG COVID-19 DECLARATION. Nursing homes and socio-medical centres are the most vulnerable resources to the coronavirus and require our support and urgent actions for protection [SPANISH TEXT]
TOPIC 28
Country of origin: UK
Centre for Evidence-Based Medicine - Oxford COVID-19 Evidence Service
TOPIC 27
Country of origin: ICELAND
Spread of SARS-CoV-2 in the Icelandic Population
TOPIC 26
Country of origin: SPAIN
Free webinar [IN SPANISH] “COVID-19. NUTRICIÓN DE LAS PERSONAS MAYORES DURANTE EL CONFINAMIENTO” organised by SEGG - Sociedad Española de Geriatría y Gerontología
TOPIC 25
Country of origin: Various Countries
TOPIC 24
Country of origin: SPAIN
POSICIONAMIENTO SEMEG RESPECTO DE LAS NECESIDADES Y DERECHOS DEL PACIENTE MAYOR EN LA SITUACIÓN ACTUAL DE PANDEMIA POR COVID-19 [SPANISH TEXT]
TOPIC 23
Country of origin: Various Countries
Respiratory virus shedding in exhaled breath and efficacy of face masks
TOPIC 22
Country of origin: Various Countries
Useful Resources for Geriatric Rehabilitation post COVID-19
TOPIC 21
Country of origin: UK
King’s Critical Care – Evidence Summary - Clinical Management of COVID-19
TOPIC 20
Country of origin: FRANCE
Measures for safety and protection of Care Homes against COVID-19
Recommendations proposed by three Professors of Geriatric Medicine in France
Hubert Blain (Montpellier), Yves Rolland (Toulouse), Athanase Benetos (Nancy)
TOPIC 19
Country of origin: CANADA
ICU Volume 10 - Issue 4 - Ethics of Triage
TOPIC 18
Country of origin: CHINA
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
TOPIC 17
Country of origin: PORTUGAL
Question: Many things are being written about prescription of Hydroxicloroquine in prevention and treatment of COVID-19 Can we start giving Hydroxicloroquine to our oldest and symptomatic patients. EuGMS has already advice about that?
Answer from EuGMS Task Force on COVID-19: From the medical/scientific point of view we have to be skeptical and seek for more data from controlled clinical studies. On the other side there is an increasing pressure because of the present situation pushing people, physicians and governments to the use of this molecule without solid evidence. We don't use Hydroxycloroquine so far but we hope to have the authorization to test it very soon in a clinical trial we initiate with several other French groups for treating older COVID-19 + patients . May be in the next days we will have some more data allowing us to make a decision.
Friday March 27th
TOPIC 16
Country of origin: UK
National Institute for Health and Care Excellence - NICE - Critical care guidance including frailty
Thursday March 26th
TOPIC 15
Country of origin: BELGIUM
COVID-19, diagnostic, PEC et spécificités SA [FRENCH TEXT]
Thursday March 26th
TOPIC 14
Country of origin: UK
BGS guidelines on management of COVID-19 pandemic in care homes
Wednesday March 25th
TOPIC 13
Country of origin: SPAIN
COVID-19 - Recommendations for nursing homes and social health centres
Tuesday March 24th
TOPIC 12
Country of origin: NORWAY
Norwegian Geriatrics Society - Recommendations and priorities from the Norwegian geriatrics society to the Norwegian health directorate in connection with the COVID-19 pandemia
Tuesday March 24th
TOPIC 11
Country of origin: Various countries
International Evidence Summary on Clinical Management of COVID-19
Monday March 23rd
TOPIC 10
Country of origin: FRANCE - VIETNAM
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial
Monday March 23rd
TOPIC 9
Country of origin: CHINA
BioScience: Letter on the use of Chloroquine phosphate
Monday March 23rd
TOPIC 8
Country of origin: UK
National Institute for Health and Care Excellence - NICE - COVID-19 rapid guideline: critical care
Monday March 23rd
TOPIC 7
Country of origin: UK
- BGS statement on the COVID-19 pandemic
- Delirium and COVID-19: Managing delirium in confirmed and suspected cases (in collaboration with European Delirium Association and Old Age Psychiatry Faculty - Royal College of Psychiatrists)
- Coronavirus: Current information and advice
Monday March 23rd
TOPIC 6
Country of origin: BELGIUM
Ethical principles concerning proportionality of critical care during the 2020 COVID-19 pandemic in Belgium: advice by the Belgian Society of Intensive care medicine
Read/Download here
TOPIC 5
Country of origin: CANADA
Discussions about COVID-19 and Frailty from CFN - Canadian Frailty Network – Explanatory Webinars:
- Acute/Critical Care
Date and Time: Fri, Mar 20, 2020 4:00 PM - 5:00 PM CET
Registration link: https://register.gotowebinar.com/register/1714829526627095554 - Residential/LTC
Date and Time: Fri, Mar 20, 2020 5:10 PM - 6:10 PM CET
Registration link: https://register.gotowebinar.com/register/3771562783405457923 - Community Care
Date and Time: Fri, Mar 20, 2020 6:20 PM - 7:20 PM CET
Registration link: https://register.gotowebinar.com/register/1825133632637341187
TOPIC 4
Country of origin: FRANCE - UK
Question: An increasing number of patients have diarrhoea as a first sign of COVID-19. The opinion of the experts is that if there is no evidence of another cause of diarrhoea, patients with this symptom should be managed as suspected COVID-19 cases. How was the diagnosis in these patients with diarrhoea made: from stool sample PCR or in the usual way with throat swabs etc?
Answer from EuGMS Task Force on COVID-19: in the usual way with throat swabs.
Wednesday, March 18th
TOPIC 3
Country of origin: PORTUGAL
Question: Do you think we can start giving chloroquine to the high-risk elderly population (dwelling elderly population)?
Does EuGMS have any guidelines on this?
I read that the National Health Commission of the People's Republic of China intends to publish guidelines suggesting administering chloroquine to prevent Covid19 infection.
Answer from EuGMS Task Force on COVID-19: There are ongoing clinical studies in order to verify the possible benefits of this treatment. For the moment, the Chinese studies do not offer some relatively solid evidence so my answer to your question is negative. I hope we will soon have some first solid results from the clinical studies in order to propose some efficient treatments.
Monday, March 16th
TOPIC 2
Country of origin: TURKEY
Question: Hi, l am a director of care home in Turkey/Izmir. We have not patient with corono vit19. But we have been put new rules about hygienic. No acceptance of visitors out of our institution Our nurses reminded the washing hands frequently to our workers and our older people
Answer from EuGMS Task Force on COVID-19: These are safe solutions, but we need to consider also that isolating these patients from their families and friends
TOPIC 1
Country of origin: SERBIA
Question: Creating a EUGMS document was really a good move regarding the recent facts about the COVID 19 virus. In the recent past years, I was interested in, I will say "grey area in geriatrics". The relationship between grandparents and grandchildren. Based also on the messages about the percentages of contamination or infection in the youngest and oldest, I have a question. Everyday life will not erase the contacts between grandparents and grandchildren. The population that is often asymptomatic in contact with high-risk populations. Is there any advice about it?
Answer from EuGMS Task Force on COVID-19: In the present expanding stage of the epidemic we have to avoid the contact between grandchildren (major vector of the disease because asymptomatic) and grandparents. Unfortunately, in families in which both parents work, grandparents play an important role especially when schools are closed as it is the case now in many countries but as far as possible this contact must be avoided.
Friday, March 13th
